HCG on TRT: Keep Your Balls Working While on Testosterone

Most people who start testosterone replacement therapy don't think much about what's happening upstream. They're focused on the downstream effects, the energy, the body composition, the mood, and for good reason, because those are the things they felt declining. But the system that produces testosterone is not a simple faucet you turn on and off. It's a feedback loop, and when you add testosterone from the outside, the loop doesn't just pause, it shuts down completely, and understanding what shuts down, why it matters, and what you can do about it is the difference between using TRT strategically and using it blindly.

So before we get into HCG and what it does, you need to see the full signal chain from top to bottom. Once you have the map, everything else clicks into place.

I have this signal that's going from my brain, GNRH, gonadotropin-releasing hormone, goes from the hypothalamus to the pituitary which produces two hormones, luteinizing hormone, follicle-stimulating hormone, those go down to the balls, they turn on the signal, luteinizing hormone tells your testicles to produce testosterone, follicle-stimulating hormone tells your testicles to produce sperm. Hypothalamus talks to pituitary, pituitary talks to testicles, and the testicles do two jobs at once: make testosterone and make sperm, two different hormones driving two different outputs from the same organ, and that's the whole chain from beginning to end.

Now the reason this pathway exists as a loop and not just a one way signal is because the brain needs to know when to stop. When testosterone levels in the blood rise high enough, the hypothalamus detects that and dials back its release of GnRH, which means the pituitary produces less LH and less FSH, which means the testicles get less stimulation, and this whole arrangement works like a thermostat in the sense that the room gets warm enough and the heater turns down. This is called negative feedback, and it's one of the most fundamental control systems in endocrinology.

The thermostat doesn't care where the heat came from, because all it does is read the temperature and respond to what it finds. So when you inject testosterone from an outside source, something called exogenous testosterone because it originates outside the body, the brain reads those rising levels the same way it would read testosterone your own testicles made. It sees the room is warm and it turns the heater off, so GnRH drops along with LH and FSH right behind it, and now the testicles are sitting there with no signal coming in at all.

The suppression that follows is not a subtle dimming of the signal so much as a near complete shutdown in many cases. Research published in Current Pharmaceutical Design by Fusco and colleagues describes how exogenous testosterone can suppress intratesticular testosterone concentrations by as much as 94 percent, even when blood levels of testosterone look completely normal. That's a critical distinction, because the testosterone inside the testicle is what drives sperm production through the Sertoli cells, and it needs to be far higher than what circulates in the bloodstream, roughly 25 to 100 times higher according to the same review. So you can have great blood work and a fully suppressed reproductive system at the same time.

This suppression doesn't happen overnight but it also doesn't take long. LH levels can begin dropping within days of starting exogenous testosterone, and within a few weeks the testicles start to physically shrink, a process called testicular atrophy. The Leydig cells, which are the cells inside the testicle that respond to LH and produce testosterone, begin to reduce in size and activity when they stop receiving their signal. Research from Toppari and colleagues in Molecular and Cellular Endocrinology has shown that LH is not just a stimulatory hormone for steroidogenesis but also plays a trophic role, meaning it literally maintains the structural integrity and size of the cells it acts on, so when you pull the signal away the tissue atrophies in much the same way a muscle you stop training loses mass and function and becomes harder to bring back to full capacity the longer you leave it alone.

This is where the concern about fertility enters the picture. Sperm production, called spermatogenesis, is driven by FSH acting on Sertoli cells inside the seminiferous tubules of the testicle. But Sertoli cells also need high local concentrations of testosterone to function properly, so even though FSH is the primary driver of sperm production, it can't do its job if the intratesticular testosterone has cratered, and both sides of that equation have been knocked out at once because the FSH signal from the pituitary has been suppressed by negative feedback and even if some FSH were still present the local testosterone environment it depends on is gone. Fusco and colleagues describe this as a dual mechanism of suppression, which is why testosterone based contraceptive strategies have historically been explored, because the suppression of spermatogenesis on exogenous testosterone is that reliable.

Now you might be wondering whether the testicles can recover from this if you stop TRT. In many cases they can, but the timeline and completeness of recovery varies. Van den Berghe and colleagues published work in the Journal of Clinical Endocrinology and Metabolism showing that even five days of pulsatile GnRH administration could begin to unveil underlying gonadal function in men whose axis had been suppressed, which tells us the machinery can come back online, but it also tells us that prolonged suppression creates a state where the whole chain, hypothalamic, pituitary, and gonadal, needs to be reactivated, not just one level. The longer the suppression lasts, the harder that reactivation becomes, and in some cases full recovery of spermatogenesis can take 6 to 24 months after stopping testosterone, with a small percentage of men not recovering to baseline at all.

So the question becomes: is there a way to keep the testicles active while on TRT? And this is exactly where HCG enters the conversation.

I know that when I introduce the exogenous testosterone, my brain is going to stop sending the signal down to my balls to make more which means my balls are going to be like, yo, I'm out of here, right? HCG is a synthetic peptide that replaces LH or replicates LH so even though my brain isn't sending the signal, I can do the HCG and now my balls still have to work to produce its own testosterone.

HCG stands for human chorionic gonadotropin, and while it's often described as synthetic, it's actually a hormone naturally produced during pregnancy by the placenta. What makes it useful in this context is that it binds to the exact same receptor on Leydig cells that LH binds to, and it's structurally similar enough that the Leydig cell can't tell the difference. So when the brain has stopped sending LH because exogenous testosterone has triggered negative feedback, HCG steps in and fills that role from the outside, and the testicle receives a signal that looks and acts like LH so it responds accordingly, producing its own testosterone and maintaining its size and function.

Two things follow from this that are worth laying out clearly, the first being testicular volume, because men on TRT who use concurrent HCG tend to maintain testicular size because the Leydig cells continue to be stimulated, they stay metabolically active, they continue steroidogenesis, and the trophic effects of receptor activation keep the cells from atrophying, and this isn't just cosmetic although that matters to some people, because testicular size is a proxy for Leydig cell mass and function so maintaining size means maintaining the machinery you'd need if you ever came off TRT and wanted your natural production to restart.

The second thing that follows is fertility, and the part most people overlook entirely is that HCG doesn't directly stimulate sperm production, because that's FSH's job through the Sertoli cells, but by keeping intratesticular testosterone levels elevated through Leydig cell stimulation, HCG creates the hormonal environment inside the testicle that Sertoli cells need to respond to whatever FSH is present. Even though FSH from the pituitary is suppressed on TRT, there may still be trace amounts circulating, and in some clinical protocols FSH can be added exogenously alongside HCG to restore full spermatogenesis. The point is that HCG preserves the foundation, and without it even adding FSH later might not be enough because the local testosterone environment has already collapsed.

Leslie and colleagues describe a condition called Sertoli Cell Only Syndrome, where the seminiferous tubules contain Sertoli cells but no germ cells, resulting in complete absence of sperm production. While this condition has genetic and developmental causes, the functional principle is informative: Sertoli cells need the right hormonal signals and the right environment to support spermatogenesis, and when either is missing, the process fails entirely. This is what prolonged unsupported TRT can mimic functionally, not the genetic condition itself, but the end result of a Sertoli cell environment starved of the intratesticular testosterone it depends on.

How much HCG and how often is protocol dependent and individualized, but typical dosing in clinical settings ranges from 250 to 500 IU given two to three times per week alongside TRT. The goal is not to replace the full output of natural LH pulsatility, which is far more complex and variable, but to provide enough receptor stimulation to keep the Leydig cells active and the intratesticular environment functional. Too much HCG can actually desensitize the LH receptor over time or cause estrogenic side effects because the testosterone it stimulates can aromatize, so more is not better. It's a maintenance signal, not a replacement for the entire axis.

There's one more layer to this that's worth understanding. The hypothalamic pituitary gonadal axis doesn't just regulate testosterone and sperm. It's connected to broader metabolic and neuroendocrine signaling. Jiang and Jorgensen published work in Molecular Reproduction and Development examining fetal Leydig cells and how early hormonal signaling shapes testicular development and function across the lifespan. The Leydig cells you have as an adult were primed by hormonal signals that began before you were born, and their sensitivity to LH, their capacity for steroidogenesis, and their resilience to suppression are all influenced by that developmental history. This means that two men on the same TRT protocol can have very different responses to suppression and very different outcomes with HCG, because their Leydig cell populations were shaped by different developmental environments. There is no universal dose or universal timeline for everyone.

The system that makes testosterone is not just a production line. It's a conversation between the brain and the testicles, with each side listening to the other, adjusting output based on what it senses, and depending on signals that were established before you were even aware you had the system. When you add testosterone from the outside, you don't break the system, but you do silence one side of the conversation, and what HCG does is not restore that conversation so much as it fakes the part of it that the testicles need to hear so they keep doing their job while the brain stays quiet. And the reason that matters is not just about ball size or fertility in the abstract, but because the day you might want the full conversation to resume, you need both sides of it to still remember how to talk.

References:

Fusco F, Verze P, Capece M et al.. Suppression of Spermatogenesis by Exogenous Testosterone. Curr Pharm Des. 2021. https://pubmed.ncbi.nlm.nih.gov/33292112/

Davolli GM, Ball BA, Esteller-Vico A et al.. Reversible downregulation of the hypothalamic-pituitary-gonadal axis in stallions with a novel GnRH antagonist. Theriogenology. 2016. https://pubmed.ncbi.nlm.nih.gov/27570103/

van den Berghe G, Weekers F, Baxter RC et al.. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab. 2001. https://pubmed.ncbi.nlm.nih.gov/11443192/

. Gonadotropins. . 2012. https://pubmed.ncbi.nlm.nih.gov/31644163/

Toppari J, Kaleva M, Virtanen HE et al.. Luteinizing hormone in testicular descent. Mol Cell Endocrinol. 2007. https://pubmed.ncbi.nlm.nih.gov/17363139/

Jiang K, Jorgensen JS. Fetal Leydig cells: What we know and what we don't. Mol Reprod Dev. 2024. https://pubmed.ncbi.nlm.nih.gov/38480999/

Leslie SW, Mejias SG, Ramphul K. Sertoli Cell–Only Syndrome. . 2026. https://pubmed.ncbi.nlm.nih.gov/30484998/

Soares DM, Silva JD, Soares AR et al.. Isolated Follicle-Stimulating Hormone (FSH) Deficiency in Male Sex: A Case Report. Cureus. 2025. https://pubmed.ncbi.nlm.nih.gov/41631229/